Skip to Main content Skip to Navigation
Journal articles

Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity.

Abstract : BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders collectively referred to as inflammatory bowel diseases (IBD). Cysteinyl leukotrienes are proinflammatory 5-lipoxygenase-derived products that play a major role in the immune and inflammatory response. Consequently, they may be involved in the pathogenesis of IBD. The aim of this study was therefore to evaluate 1) the urinary excretion of leukotriene E(4) (LTE(4)) in IBD patients and healthy volunteers, and 2) the association between LTE(4) production and the activity (relapse/remission) of the disease. METHODS: IBD patients and healthy volunteers were prospectively recruited. CD and UC activity was determined on inclusion with the Crohn's Disease Activity Index and Clinical Activity Index, respectively. Urine was collected and the urinary excretion of LTE(4) was measured by liquid chromatography tandem mass spectrometry. RESULTS: 32 CD patients, 28 UC patients, and 30 controls were enrolled in the study. LTE(4) urinary excretion was significantly increased (P < 0.01) in CD [52.0 pg/mg creatinine (10th-90th percentiles: 26.2-148.0)] and UC [64.1 pg/mg creatinine (10th-90th percentiles: 26.7-178.0)] patients compared to controls [32.3 pg/mg creatinine (10th-90th percentiles: 21.8-58.8)]. LTE(4) levels were higher (P < 0.001) in patients with active disease than in patients in remission, for whom the levels of LTE(4) were similar to the levels of controls. CONCLUSIONS: Cysteinyl leukotriene pathway activation could contribute to the inflammation associated with IBD. The quantification of urinary LTE(4) could be an interesting noninvasive biomarker for the assessment of IBD activity.
Complete list of metadata

Cited literature [17 references]  Display  Hide  Download
Contributor : Valérie Sinniger Connect in order to contact the contributor
Submitted on : Saturday, October 3, 2009 - 6:13:33 PM
Last modification on : Monday, May 16, 2022 - 10:46:01 AM
Long-term archiving on: : Saturday, November 26, 2016 - 9:28:11 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Françoise Stanke-Labesque, Joanna Pofelski, Alexandre Moreau-Gaudry, Germain Bessard, Bruno Bonaz. Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity.. Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2008, 14 (6), pp.769-74. ⟨10.1002/ibd.20403⟩. ⟨inserm-00385624⟩



Record views